Therapeutic Advances in Hodgkin Lymphoma

Oncologist Jakub Svoboda, MD, offers an overview of recent advances in the treatment of Hodgkin Lymphoma, including new biological and targeted agents, optimal combinations and the evolving concept of limiting therapy to better manage acute and long-term toxicities while achieving cure.



Related Links


August 14, 2014

Created by

Penn Physician VideoLink